Target
Metabotropic glutamate receptor 3
Ligand
BDBM50204256
Substrate
n/a
Meas. Tech.
ChEMBL_1627029 (CHEMBL3869550)
IC50
30±n/a nM
Citation
 Dressman, BATromiczak, EGChappell, MDTripp, AEQuimby, SJVetman, TFivush, AMMatt, JJaramillo, CLi, RKhilevich, ABlanco, MJSmith, SCCarpintero, Mde Diego, JEBarberis, MGarcĂ­a-Cerrada, SSoriano, JFSchkeryantz, JMWitkin, JMWafford, KASeidel, WBritton, TOvershiner, CDLi, XWang, XSHeinz, BACatlow, JTSwanson, SBedwell, DOrnstein, PLMitch, CH Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depression. Bioorg Med Chem Lett 26:5663-5668 (2016) [PubMed]  Article 
Target
Name:
Metabotropic glutamate receptor 3
Synonyms:
metabotropic glutamate 3 | metabotropic glutamate 3/1a | metabotropic glutamate 3/1c | GRM3_HUMAN | GRM3 | GPRC1C | MGLUR3
Type:
Enzyme Catalytic Domain
Mol. Mass.:
98889.09
Organism:
Human
Description:
metabotropic glutamate 1c 0 HUMAN::Q14832
Residue:
879
Sequence:
MKMLTRLQVLTLALFSKGFLLSLGDHNFLRREIKIEGDLVLGGLFPINEKGTGTEECGRINEDRGIQRLEAMLFAIDEINKDDYLLPGVKLGVHILDTCSRDTYALEQSLEFVRASLTKVDEAEYMCPDGSYAIQENIPLLIAGVIGGSYSSVSIQVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFYQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFEQEARLRNICIATAEKVGRSNIRKSYDSVIRELLQKPNARVVVLFMRSDDSRELIAAASRANASFTWVASDGWGAQESIIKGSEHVAYGAITLELASQPVRQFDRYFQSLNPYNNHRNPWFRDFWEQKFQCSLQNKRNHRRVCDKHLAIDSSNYEQESKIMFVVNAVYAMAHALHKMQRTLCPNTTKLCDAMKILDGKKLYKDYLLKINFTAPFNPNKDADSIVKFDTFGDGMGRYNVFNFQNVGGKYSYLKVGHWAETLSLDVNSIHWSRNSVPTSQCSDPCAPNEMKNMQPGDVCCWICIPCEPYEYLADEFTCMDCGSGQWPTADLTGCYDLPEDYIRWEDAWAIGPVTIACLGFMCTCMVVTVFIKHNNTPLVKASGRELCYILLFGVGLSYCMTFFFIAKPSPVICALRRLGLGSSFAICYSALLTKTNCIARIFDGVKNGAQRPKFISPSSQVFICLGLILVQIVMVSVWLILEAPGTRRYTLAEKRETVILKCNVKDSSMLISLTYDVILVILCTVYAFKTRKCPENFNEAKFIGFTMYTTCIIWLAFLPIFYVTSSDYRVQTTTMCISVSLSGFVVLGCLFAPKVHIILFQPQKNVVTHRLHLNRFSVSGTGTTYSQSSASTYVPTVCNGREVLDSTTSSL
  
Inhibitor
Name:
BDBM50204256
Synonyms:
CHEMBL3948272
Type:
Small organic molecule
Emp. Form.:
TBD
Mol. Mass.:
TBD
SMILES:
TBD
Structure:
Search PDB for entries with ligand similarity: